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1 Introduction 
1.1 Routine ultrasound examination in Norway 
Routine ultrasound screening in pregnancy was introduced in Norway after a consensus 
conference on ultrasound in pregnancy in 1986 (1). A similar conference had been 
conducted in USA, 1984 (2). The conclusion from that conference was that ultrasound 
was a valuable examination in pregnancy, but that there were no basis for introducing 
routine use of ultrasound in all pregnancies.  At that time, only West-Germany had 
established ultrasound screening in pregnancy. In most other European countries, the 
official recommendation was to use ultrasound on clinical indications only. 
 
The consensus panel summarized the arguments for offering one ultrasound 
examination in Norway in this way(1): 
• A total of 94% of the pregnant women were examined with ultrasound during 
their pregnancy. The mean number of examinations performed was 2.45(3). 
• Many obstetrical departments practiced routine ultrasound, but considerable 
differences were shown between the regions. The proportion of the pregnant 
women that were offered routine ultrasound varied from 83 % in health region 1 
to 61 % in region 3. The number of routine examinations varied, as well as the 
time in pregnancy, the purpose and the content of the examinations. Hence, it 
may be concluded that the quality of the examinations as well as the utility 
varied considerably. Also, there was no quality assessment of the technical 
apparatus and no systematic education of the personnel (3). 
• The general opinion in Norway is that antenatal care should be similar 
throughout the country 
 
The consensus panel stated that: 
• Every pregnant women should be offered one routine ultrasound 
examination  at approximately the 17th week of gestation 
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• For the purposes of continuous quality control, registration of selected 
data from all ultrasound examinations in pregnancy should be 
established. 
• The examinations must be conducted by personnel with specialized 
competence – preferably gynaecologists and midwives. 
• Responsibility for organizing ultrasound examinations in a given 
geographical area must be clearly defined. 
• Effective means must be employed to reduce the current over utilization. 
• The examination should preferably be conducted at the maternity 
department where the woman is expected to deliver 
• Personnel conducting ultrasound examinations must have sufficient time 
for the women examined. Information should preferably be both written 
and oral. The written information must be given well in advance of the 
examination itself. 
 
For the purpose of quality control, the consensus panel recommended that a systematic 
registration of selected data from all ultrasound examinations should be established (1). 
 
Shortly after the consensus conference the consensus statement was approved by the 
Directorate of Health and submitted to doctors and midwives as a guideline for the use 
of ultrasound in pregnancy, replacing the recommendation not to screen from 1984 (4). 
 
In the following years, the public debate became more focused on detection of fetal 
malformations. This aspect of routine ultrasound was not dealt with in detail in the 
1986-conference, as the standard of the equipment at that time limited the examination 
of fetal anatomy. However, both the ultrasound technology and the skills of the 
ultrasound operators improved over the years. A broad ethical debate was raised and 
parliamentarians urged the Health Authorities to initiate a new consensus conference. 
As part of the program for medical technology assessment, the National Norwegian 
Research Council in 1995 organized the second Norwegian consensus conference on 
routine ultrasound in pregnancy (5). In the consensus statement, the recommendation 
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from 1986 to offer one routine examination in gestational week 18 was repeated. The 
panel concluded that screening for fetal malformations was an integrated part of the 
routine ultrasound examination. The panel recommended research in the following 
areas: 
• Pregnancies that are post-term pregnancies according to estimated day of 
delivery by ultrasound. 
• Cases where the biological EDD differ from the EDD made by ultrasound. 
• Research on the usefulness for the newborn child of finding a congenital 
anomaly at routine ultrasound screening. 
 
1.2 Establishment of a perinatal database in Oppland 
Quality assurance and quality improvement of obstetrical care has always been one of 
my main interests. Systematic recording of results is a prerequisite for quality assurance 
of clinical work. In 1986, at Lillehammer Central Hospital we started to develop a 
computer program to record information from the ultrasound screening, and information 
about the deliveries. A pilot version was taken in use in May 88 and from January 1. 
1989 the registration program was integrated in the data system at the hospitals in 
Lillehammer and Gjøvik as part of the hospital record system. 
 
In the county of Oppland, the rule is that routine ultrasound examinations are performed 
by midwifes and doctors in the obstetrical departments of Lillehammer and Gjøvik 
Central Hospitals. Also, two specialists in gynaecology and obstetrics working in the 
city of Lillehammer and one general practitioner working in Otta 110 km from 
Lillehammer perform the routine examinations in their own patients. 
 
The deliveries in the county are managed by the obstetric departments of Lillehammer 
and Gjøvik Central Hospitals, and two small cottage hospitals (Lom and Valdres 
fødestogo). The cottage hospital in Lom had only very few deliveries, and was closed in 
1995. 
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When the patients are discharged from the obstetric departments after delivery, 
information about the pregnancy and the delivery is prospectively recorded in the 
database by obstetricians examining the records. From the cottage hospitals, 
information about the deliveries is sent to Lillehammer and recorded in the database. 
 
The annual number of deliveries in the county is approximately 2000. Thus, the 
perinatal databases presently comprise detailed information about more than 30 000 
deliveries. The completeness of the database is routinely checked against the hospital 
discharge registry. 
 
The utility of collecting this information has repeatedly been demonstrated. For 
example, in January every year since 1989 the obstetrical department of Lillehammer 
central hospital has issued an annual report highlighting relevant topics in antenatal care 
and obstetrical care. One of the topics has been smoking in pregnancy, where there is a 
large and consistent difference between women in Gudbrandsdalen and women from the 
southern part of Oppland, where smoking is more prevalent. Also, from 1989 the 
ultrasound operators receive an annual personal report on their performance. For each 
individual ultrasound operators, the mean difference between EDD according to 
ultrasound and observed day of delivery is computed. Then, the individual operator can 
compare her own performance with that of the others, but the identity of the others is 
not revealed. There are examples that doctors and midwives have adjusted their 
measurement technique and improved their results following this feed back. Also, in the 
follow up of an increase in obstetric sphincter injuries we were able to identify care 
providers with results indicating the need for improvement.  Midwifes are also given an 
annual report. She can then compare her own results against the mean of the delivery 
department. This has often resulted in a change in midwifery practice. 
 
Thus, our experience is that a computerized record system compiling relevant 
information in a perinatal database is an excellent tool for quality assurance, 
management and planning of obstetrical services. The database has led to a number of 
other publications (6-9). This dissertation will provide additional proof that a county 
wide perinatal database can be useful for research purposes. 
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2. Aims of the study 
 
The aims of the study were: 
 
To assess the risk for adverse obstetrical outcome in women where the EDD had 
been postponed more than 14 days with ultrasound. 
 
To evaluate the mortality and morbidity of conservatively managed post-term 
pregnancies (gestation 294 days and beyond). 
 
To assess the sensitivity for detecting fetal congenital anomalies with routine 
mid second trimester ultrasound performed in a routine clinical setting. 
 
To estimate the random or biologic uncertainty of gestational age based on LMP 
and on routine ultrasound. 
 
To compare the performance of the new Norwegian reference values for BPD 
measurement with the old reference values. 
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3. List of papers 
 
The thesis is based on five papers. The papers will be referred to by their Roman 
numerals. 
 
Paper I Adverse obstetric outcome in fetuses that are smaller 
than expected at second trimester routine ultrasound 
examination. 
Nakling J, Backe B. Acta Obstet Gynecol Scand, 2002; 81: 846-51. 
  
Paper II Pregnancy risk increases from 41 weeks of gestation. 
Nakling J, Backe B. Acta Obstet Gynecol Scand 2006 (in press). 
 
Paper III Routine ultrasound screening and detection of 
congenital anomalies, outside a university setting. 
Nakling J, Backe B. Acta Obstet Gynecol Scand, 2005; 84: 1042-8. 
 
Paper IV The biologic error in gestational length related to the use 
of the first day of last menstrual period as a proxy for the 
start of pregnancy. 
Nakling J, Buhaug H, Backe B. Early Hum Dev. 2005;81(10):833-9. 
Paper V Term prediction with ultrasound: Evaluation of a new 
dating curve for BPD measurements.   
Backe B, Nakling J. Acta Obstet Gynecol Scand 2006 (in press). 
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Erratum: 
Paper I:   
Figure 1 and Figure 2 are confused. The legends are correct but the figures should be 
replaced with each other. 
.
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4. Material and methods 
 
4.1 The study population  
 
The thesis is based on information collected in the perinatal database from January 1. 
1989 until December 31. 1999. Included in the study were women who were residents 
of Oppland county and who received their antenatal care inclusive the routine 
ultrasound examination in Oppland. Obstetrical care is provided by the two hospitals 
situated in the county (Lillehammer and Gjøvik) and two small cottage hospitals. 
Women living in the southernmost community, Jevnaker, in Oppland have routine 
ultrasound and delivery at Ringerike hospital in Hønefoss, in the neighbouring county 
of Buskerud. Women from this community were not included.  Also, women 
temporarily living outside the county (i.e. students) were not included.  
 
Cases with extreme prematurity (< 28 weeks gestation) are referred to the regional 
hospital in Oslo (Ullevaal University Hospital) and cases with fetal malformations are 
referred to the National Centre for Fetal Medicine at St Olavs Hospital in Trondheim. 
Information about patients who delivered at one of the two tertiary care hospitals after 
referral was collected and recorded in the database.  
 
Thus, the total background population comprised 23 158 women (10), who had a total 
of  19,823 deliveries during the 11 year period 1989 to 1999.  
 
4.2 The routine ultrasound examination 
In Oppland county, routine ultrasound was introduced about 1985. Thus, the practice in 
Oppland was already in correspondence with the recommendations when the Health 
Directorate issued their guidelines in 1986. The routine ultrasound examination is 
performed in gestational week 18. The women are referred from the general practitioner 
of midwife. 
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The standard procedure comprises measurement of fetal biparietal diameter and 
assessment of gestational age by use of the standard Norwegian reference chart, and 
localization of the placenta. Also, the fetal anatomy is checked systematically. The 
checklist for fetal anatomy introduced by Eik Nes in 1985 (“blåskjema”) is used.   
 
About 70 % of the routine ultrasound examinations were performed by four midwives, 
trained at the National Centre for Fetal Medicine, St Olavs Hospital, Trondheim. The 
largest part of the remaining examinations (Table 1) was performed by consultant 
obstetricians at the two obstetric departments. The two obstetrician gynaecologists in 
private practice and the one general practitioner performed only a limited number of 
routine examinations 
 
Table 1 Number of examinations  
 Number of examinations 
Midwife 1 4477
Midwife 2 4348
Midwife 3 3662
Midwife 4 905
OB in hospital 4501
OB outside hospital and GP 737 
 
Pregnant women in Oppland comply with the recommendation to have one routine 
examination. Of the 19,823 deliveries, only 609 (3.1 %) had missing information about 
the routine ultrasound examination. 
 
At the ultrasound session, the midwife or doctor examine the women about the previous 
obstetric history, use of OC and the smoking habits. The information collected is 
recorded in the computer, using a locally developed obstetric data program. LMP is 
classified as reliable provided that the date of the LMP is recalled with certainty and the 
menstruation has been regular with interval within 26-32 days, and oral contraceptives 
have not been used during the last three months prior to conception. When the LMP is 
reliable, the EDD is calculated by addition of 282 days to the date of the LMP. This 
calculation is performed automatically by the computer when the data are entered. 
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The ultrasound equipment used was Hitachi EUB-410, Hitachi EUB-415, with 3·5 MHz 
and 5 MHz curvilinear transducers. Sound velocity was calibrated to 1540 m/s. The 
biparietal diameter was measured from the outer to the outer contour of the parietal 
bone echo. The day of delivery was predicted according to the standard Norwegian 
reference values issued by Eik-Nes (11), assuming a pregnancy length of 282 days. An 
EDD was only recorded when the fetal biparietal diameter was within the range of 35 to 
60 mm, corresponding to 15-22 completed weeks of pregnancy 
 
All clinical decisions were based on EDD ultrasound. 
 
4.3 Definitions 
Women were classified as smokers if they were daily smokers at the time of routine 
ultrasound examination. Perinatal death was defined as stillborn fetuses exceeding 22 
completed gestational weeks (154 days) and deaths within 7 days after delivery, 
according to the WHO recommendations (12).  Pregnancies were classified as post-term 
when gestational length exceeded 296 days, which is 14 days after EDD ultrasound. 
 
The standard Swedish-Danish normal weight-for-gestational age curve for births after 
153 days of gestation (13) was used as reference. SGA was defined as birth weight < 2 
SD from the mean.  
 
All newborns at Lillehammer and Gjøvik hospitals were routinely examined by a 
paediatrician. The first examination was during the first 48 hours after delivery. The 
children born in the two cottage hospitals were examined by a general practitioner. The 
results of the examination were recorded in the database.  
 
4.5 Statistical methods 
Statistical Package for the Social Sciences (SPSS) Version 10.0 and 12.0 was used for 
data management and statistical analyses.  
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Statistical tests included univariate tests (T-test and Chi square test) and multivariate 
tests with multiple logistic regression analysis. Relative risks and odds ratio with 95% 
confidence intervals were used. The p-values and 95% confidence intervals are reported 
where appropriate. p-values <0.05 are termed significant.  
 
4.6  Paper I 
Adverse obstetric outcome in fetuses that are smaller than expected at second 
trimester routine ultrasound examination. 
 
Included in the study were women with singleton pregnancies, who had a reliable LMP 
and an EDD based on routine ultrasound scan. A total of 16,302 singleton pregnancies 
(82.2%) were eligible for analyses.  
 
Outcome variables were perinatal death, preterm delivery (< 37 weeks), birth weight < 
2,500g and SGA.  
 
4.7 Paper II 
Pregnancy risk increases from 41 weeks of gestation. 
 
Included were women with singleton pregnancies who had a second trimester 
ultrasound examination and delivery after 37 weeks (259 days) gestation. A total of 
17,493 pregnancies were included. 1,336 (7,6 %) of the pregnancies continued beyond 
294 days of gestation. 
 
Outcome variables were perinatal death, Apgar score<7 at 5 minutes and transferral to 
NICU. 
 
The relative risk for adverse perinatal outcome was calculated the conventional way 
comparing perinatal mortality in foetuses of certain gestational age to perinatal 
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mortality for all pregnancies. We also calculated perinatal mortality and relative risk per 
ongoing pregnancy, using the number of ongoing pregnancies as the denominator. 
 
4.8 Paper III 
Routine ultrasound screening and detection of congenital anomalies, outside a 
university setting. 
 
We excluded 676 women where the routine midtrimester ultrasound examination had 
been performed outside the county, and 317 women who were examined in the 
county with normal results, but who delivered outside the county.  A total of 18 181 
pregnancies were included. Outcome variables were congenital anomalies detected at 
ultrasound examination and by postpartum paediatric examination. 
 
The fetal anomalies were grouped according to their likely clinical consequences 
according to the classification system proposed by the UK Royal College of 
Obstetricians and Gynaecologists in 1997 (14). The anomalies were also categorized 
according to the anatomical localization. 
 
4.9 Paper IV 
The biologic error in gestational length related to the use of the first day of last 
menstrual period as a proxy for the start of pregnancy 
 
Included were women with singleton pregnancies and spontaneous onset of labor, 
where an EDD based on routine ultrasound was recoded as well as  EDD based on a 
reliable LMP. The study comprised 11,238 pregnancies.  The difference between 
observed and predicted day of delivery according to either method and the difference 
between the two EDDs were calculated. The variances of the differences were 
combined to estimate the variance of the time from LMP to the start of pregnancy, and 
the variance of the difference between real and ultrasound assessed gestational age. 
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4.10 Paper V 
Term prediction with ultrasound: Evaluation of a new dating curve for BPD 
measurements. 
The study population of Paper V is the same as in Paper IV.  Included were women with 
singleton pregnancies and spontaneous onset of labor, where an EDD based on 
ultrasound was recorded as well as an EDD according to a reliable menstrual history. 
Elective caesarean sections and cases where labor was induced were excluded. The 
study population comprises a total of 11,238 deliveries. 
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5. Main results  
 
Paper I 
Adverse obstetric outcome in fetuses that are smaller than expected 
at second trimester routine ultrasound examination. 
 
In 1,133 pregnancies (7%) the EDD was postponed with more than 14 days.  
The central finding is that these pregnancies carry a statistically significant increased 
risk for perinatal death, preterm birth, SGA and low birthweight. This effect is 
independent of smoking, age, parity and major anomalies (included chromosomal 
aberrations). Also, the effect is not associated with irregular ovulation due to recent OC 
use.  
 
Paper II 
Pregnancy risk increases from 41 weeks of gestation. 
 
A total of 1,336 (7.6 %) of the deliveries were post-term. If RR is calculated per 
ongoing pregnancies, the risk for perinatal mortality as well as morbidity increased 
significantly after week 41, despite intensive surveillance of patients that were allowed 
to continue their pregnancies after week 42+2. 
 
Our results indicate that management of post-term pregnancies can be improved, and 
that intensified observation should be started earlier than gestational week 42+2. 
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Paper III 
Routine ultrasound screening and detection of congenital 
anomalies, outside a university setting. 
 
Altogether, there were 267 foetuses and newborns with anomalies (1.5 %). 104 cases 
were detected with routine ultrasound (38.7 %). There were 11 false positives (renal 
pelvic dilatation that were not confirmed after birth) and 163 cases that remained 
undiagnosed (false negatives), which gives a specificity of 99.9 % and a positive 
predictive value of 90.4 %. 
The sensitivity for detecting anomalies in the central nervous system was 69.4%, and 
for the cardiac system it was 14.5%. The detection rate for lethal anomalies was 
80.0%, and in 31 of 32 cases a TOP was performed. All pregnancies that ended in 
termination (57 cases) had a second opinion examination at the National centre for 
fetal medicine. In all cases post-mortem examination confirmed the major ultrasound 
findings. There were thirty-eight chromosomal aberrations and ten of them were 
found at midtrimester ultrasound examination and confirmed by karyotyping 
(26.3%). 
Paper IV  
The biological error in gestational length related to the use of the 
first day of last menstrual period as a proxy for the start of 
pregnancy 
 
The period from LMP to start of pregnancy had a biologic variation of 7.0 days (SD). 
The random error of ultrasound dating was estimated to 5.2 days (SD). 
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Paper V 
Term prediction with ultrasound: Evaluation of a new dating curve 
for BPD measurements. 
 
When EDD was based on the new reference values for BPD, the difference between 
observed and predicted day of delivery was significantly closer to zero than when the 
old reference values were used. Also, when EDD was based on small BPDs the 
prediction error of the old method increased up to 7 days. 
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6. Discussion 
 
Gestational age assessment with ultrasound biometry is based on the assumption that in 
early pregnancy, foetuses of same age are of same size. This assumption is clearly an 
approximation, the individual variation increases with increasing gestational age. The 
assumption that all foetuses are of average size in gestational week 18 leads to a 
misclassification of foetuses that are larger or smaller than the average. The question is 
whether the resulting error is large enough to have practical consequences or whether 
this is purely of academic interest. So far, the published studies have been inconclusive, 
and the first study in the thesis (Paper I) addressed this question. 
 
In foetuses that are smaller than expected at routine ultrasound, the EDD ultrasound will 
be postponed relative to EDD based on menstrual history. If the pregnancy is managed 
according to EDD ultrasound, it may then have adverse consequences for example in 
post term pregnancies falsely believed to be term pregnancies. 
 
As reported in paper I, adverse perinatal outcome (perinatal death, preterm delivery, low 
birthweight and SGA) is significantly increased in pregnancies where the expected term 
of delivery is postponed with more than 14 days. This adverse effect was not due to 
confounding caused by maternal age, smoking, use of OCs and major anomalies. For 
three of the four outcomes there was a clear and statistically significant trend towards 
increasing risk with increasing discrepancy between the two EDDs. The perinatal deaths 
occurred at all gestational ages, and were not caused by mismanagement of post term 
pregnancies. Seven percent of the population had their EDD postponed with more than 
14 days, and the population attributable risk proportion for each of the four outcomes 
varied from eight to four percent. 
 
Thus, we can conclude that gestational age discrepancy is an important risk factor 
affecting about 7 % of the pregnancies, and this risk factor carries a considerable 
proportion of perinatal morbidity and mortality. Still, we do not know how to manage 
pregnant women where the EDDs differ with more than two weeks. If effective 
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interventions were identified this would be an important contribution. This may be an 
effect of early growth restriction. Routinely, in cases with two weeks discrepancy we do 
now offer a follow up examination with ultrasound fetometry in week 25. 
 
Also, I will emphasize the point that the women’s information about LMP is not 
disregarded or ignored. This information should be respected and may contain valuable 
information. 
 
The second paper (Paper II) deals with post term pregnancies. One of the important 
changes in contemporary obstetrics is that the proportion of post term pregnancies is 
substantially reduced. According to the annual reports from the Medical Birth Registry 
of Norway (http://www.fhi.no), in the 1970-ies gestational length of 42 weeks was 
recorded in about 10 percent of pregnancies and about 5 percent reached 43 weeks. In 
2002, only 5.7 % of pregnancies lasted 42 weeks and 0.2 % reached 43 weeks 
(http://www.fhi.no). This reduction of post term pregnancies is an effect of ultrasound 
dating, providing a more reliable EDD that what can be calculated from LMP. Albeit 
less frequent the individual risk associated with post term pregnancy may have 
increased. In earlier times when gestational length was calculated from LMP, the group 
of post term pregnancies also contained women who were wrongly classified as post 
term and the risk was diluted. 
 
The approach suggested by Hilder et al (15) computing gestation –specific risks also 
triggered my interest. In my opinion this seems to be the appropriate way to assess the 
woman’s individual risk when passing 42 weeks gestation. If risk is calculated the 
conventional way with the total population in the denominator, the actual risk that the 
individual is exposed to at 42 weeks gestation is underestimated. The gestation specific 
risk reflects the clinical situation where the obstetrician must make decisions about 
delivery or continued monitoring. 
 
In Paper II, we report the obstetric risk associated with post-term pregnancy.  When risk 
is calculated the conventional way, perinatal morbidity is significantly increased but the 
risk for mortality does not reach statistical significance. When relative risk is calculated 
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as risk in ongoing pregnancy, both morbidity indicators and risk for perinatal death is 
increased. Low Apgar score and transfer to NICU were used as indicators of morbidity, 
and this two parameters as well as the risk for perinatal death increased significantly 
after gestational week 41. Commonly, very large materials are required to analyze the 
impact of risk factors on perinatal mortality. With this approach, we can show that in 
our hands, the management of post term pregnancy is still associated with increased 
perinatal morbidity and mortality. 
 
The tradition in Norway is to follow pregnancies with no complications or disorders up 
to 43 weeks with close monitoring from week 42+2 according to ultrasound. This 
approach is also described in the guidelines of the Norwegian Society for Obstetrics and 
Gynecology (16). However, our work (Paper II) indicates that expectant management of 
post term pregnancies does not eliminate the excess risk. 
 
The problems caused by post term pregnancies previously dominated obstetrical care. 
The reduction of the number of pregnancies assumed to be 42 weeks is one of the 
important achievements of routine ultrasound, on the other hand it might well be that 
post term pregnancy to day implies a larger risk than in earlier times. Thus, it might be 
that increased surveillance should start earlier. The mean systematic error of the 
standard ultrasound method applied (Paper V) of two days should also be kept in mind, 
at gestational week 42+2 the true gestational length is probably 42+4 which might be of 
some importance. In our clinical work, we now use the new ultrasound standard values 
(Paper V) and we start monitoring post term pregnancies in week 42+0. The combined 
effect is that monitoring is started four days earlier than hitherto.  
 
The issue of fetal malformations’ screening with ultrasound has been much debated in 
the public as well as among professionals. Paper III addresses the question of whether 
routine ultrasound performed in local district hospitals can achieve detection rates 
comparable with “centres of excellence”. Comparisons of different studies are not easy 
because results are reported in different ways. A standardization of the reporting is 
required, like for example the proposal of the Royal College of Obstetricians and 
Gynaecologists (14) grouping the malformations according to their likely clinical 
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consequences. In group 1 (lethal anomalies) 80 % of the cases were detected and the 
detection rate in group 2 (anomalies associated with possible survival and long term 
morbidity) was 33 %. In the small but important group of anomalies amenable to 
intrauterine therapy (group 3) 2 of 3 cases were detected. One fetus with urinary 
obstruction, dilated renal pelvis due to uretric obstruction, was not identified antenatally 
but diagnosed after delivery. The 11 false positive findings were renal pelvic dilatation 
not confirmed after delivery, and thus without clinical significance. The greatest 
diagnostic problems were associated with detection of heart malformations and 
detection of chromosomal aberrations that are not associated with structural anomalies.  
 
Compared with results reported in the literature, our malformation screening provides 
good results with detection rates comparable with results reported from university 
centres. However, it is possible to use more resources on malformation screening. We 
have deliberately limited the efforts. For example, we do not systematically screen 
foetuses for markers of chromosomal disorders, and we have not yet taken up first 
trimester ultrasound screening with assessment of nucheal translucency. Until presently, 
in our population the emphasis on general malformation screening has been rather 
limited. It is our impression that the demand for this offer is limited. Also, we provide 
secondary obstetrical care in a widespread, rural population. The resources available are 
limited and it is a pertinent question what the priorities should be. 
 
The tradition which probably is older than Nägele (17) is to calculate pregnancy length 
from LMP. Studies about the interval from LMP to ovulation, conception or 
implantation, are remarkably few. The variation of this interval is largely unknown. 
This unknown biologic variation is responsible for a considerable uncertainty in 
gestational length assessment when counted from LMP. In Paper IV, we combined the 
results of two methods for prediction of the EDD to obtain estimates of the magnitude 
of this unavoidable random error. We estimated the SD of this interval to 7.0 days. This 
value is of the same magnitude as measured values reported in smaller studies, and also 
comparable with a reported estimate using a different approach. The implication is that 
even in women with reliable LMP, the uncertainty about when pregnancy actually 
started is considerable. Following statistical theory, this biologic variation will be within 
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+/- 7 days in 65 % of the pregnancies whereas in the remaining 35 % the variation is > 
+/- 7 days. The estimate of the random variation of ultrasound term prediction is 
approximately 5 days (SD). This provides an indication that ultrasound assessment of 
gestational length is more precise than counting from LMP. Another important message 
is that reliable information about the LMP is not equal to reliable information about 
onset of pregnancy. 
 
Ultrasound assessment of gestational duration is based upon biometry in early 
pregnancy. The obtained measure (in our setting BPD) is compared with a set of normal 
values. For more than 20 years we have used the normal values introduced by Eik-Nes 
(18),  but new standard normal values were recently introduced (19). This urged us to 
evaluate the new standards, if there were large differences it would certainly cast doubt 
on our previous work (i.e. Paper I and Paper II ) and then it would also have been 
pertinent to reassess some of our clinical results. 
 
In Paper V we showed that for BPD measurements, use of the new normal values yields 
smaller mean and median prediction errors than the old values. For comparisons of this 
type, the median should be preferred for statistical reasons (Paper V). With the new 
standard the median difference between observed and expected EDD was +1 day and 
for the old method the difference was -2 days. That is, spontaneous delivery (median) 
occurred one day after or two days earlier then the predicted day. This is a small and 
usually insignificant difference. However, in post term pregnancies two days difference 
between true and estimated gestational age might be of clinical importance, especially if 
the limit for intervention is set out further two days. As described in Paper II, the 
tradition in Norway has been to define post term pregnancy from 296 days. Our clinical 
results of the management of post term pregnancies can be improved (Paper II), and we 
have adjusted our routines by using the new standard values and by starting increased 
surveillance from week 42+0. It has been suggested (20;21) that induction should be 
discussed with the woman after week 41+0. However, further randomized trials are 
needed. 
 
 34
More important that the small average systematic error of – 2 days is the error caused by 
the old reference values when gestational age is assessed in early second trimester 
(Paper V). This problem has been identified earlier (22). In Paper V, we report that the 
prediction error increased up to 7 days when the ultrasound examination was done in 
gestational week 15 to 16. The impact of this is error is limited as only 3 % of our 
population was examined at that time in pregnancy; more than 2/3 were examined in 
weeks 18 and 19 where the difference between the methods is two days. 
I must however discuss the possible impact of incorrect dating of pregnancies in relation 
to Paper I. The routine ultrasound examination is assumed to take place in week 18-19, 
and women where gestational length for example was two weeks shorter than expected 
were incorrectly estimated to be 16-17 weeks. If the new standards had been used, 
gestational length would have been corrected with less than two weeks. In 
epidemiological terms, the error caused by the old standard values leads to a non 
differential misclassification causing a bias towards 0. The observed trend to adverse 
perinatal outcome would have been larger if the new standard values had been used. 
 
After 9 controlled randomized trials comprising more than 34,000 pregnant women, it 
has been shown that routine ultrasound provides a more precise estimate of the expected 
day of delivery, earlier detection of twin pregnancies and improved detection rates for 
fetal malformations (23). These findings clearly reflect that routine ultrasound improves 
the clinical management of the parturient women. The fetal outcome is, however, not 
improved. Important outcome indicators like the distribution of Apgar score, admission 
to NICU or perinatal mortality are not significantly influenced by routine ultrasound 
(24). It might however be futile to claim that new elements should be taken up in the 
antenatal care only on the condition that this leads to a further reduction of perinatal 
mortality. Perinatal mortality is presently about 6 per 1000, and from perinatal audits we 
know that only 20-30 % of the deaths are avoidable. Thus it is very hard to achieve 
further reductions in perinatal mortality and very large trials would be needed 
 
To demonstrate a reduction of perinatal mortality from 6 to 4 per 1000 in a randomized 
trial, with α=0,05, β= 80 %, p1= 6 ‰, p2=4 ‰  a randomized trial would require at least  
20,000 participants. 
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In my opinion, improved clinical management of pregnant women is an important goal 
in itself, documentation of improved perinatal mortality rates should not be a mandatory 
requirement.  
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7.Conclusions 
From the study population of 19,823 deliveries it was possible to answer some of the 
questions raised at the two consensus conferences of ultrasound in pregnancy. 
1. Foetuses that are smaller than expected at the second-trimester ultrasound 
corresponding to a discrepancy of more than 14 days, have an increased risk 
for adverse obstetric outcome. 
2. Expectant management of post term pregnancies allowing pregnancies to 
continue up to week 43 still carries a risk for perinatal mortality and 
morbidity, despite intensified observation from week 42+2. The risk 
increases already from gestational week 41. 
3. Mid second trimester ultrasound examination in district hospitals can 
achieve a detection rate of congenital anomalies comparable with tertiary 
centres, without few false positives that were clinically of minor importance. 
4. Even when the last menstrual period is reliable, the biological variation of 
the time from last menstrual period to the real start of pregnancy is 
substantial. Reliable information about last menstrual period is not 
equivalent to reliable information about the time of onset of pregnancy. 
5. Using the new BPD reference values gives a better prediction of spontaneous 
labor and provides a more reliable assessment of gestational age than the old 
method. 
 38
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Abstract 
Objective: In a large unselected population of normal spontaneous pregnancies, to 
estimate the biologic variation of the interval from the first day of the last menstrual 
period to start of pregnancy, and the biologic variation of gestational length to 
delivery; and to estimate the random error of routine ultrasound assessment of 
gestational age in mid-second trimester. 
Study des/gn: Cohort study of 11,238 singleton pregnancies, with spontaneous onset 
of labour and reliable last menstrual period. The day of delivery was predicted with 
two independent methods: According to the rule of Nägele and based on ultrasound 
examination in gestational weeks 17-19. For both methods, the mean difference 
between observed and predicted day of delivery was calculated. The variances of 
the differences were combined to estimate the variances of the two partitions of 
pregnancy. 
Results: The biologic variation of the time from last menstrual period to pregnancy 
start was estimated to 7.0 days (standard deviation), and the standard deviation of 
the time to spontaneous delivery was estimated to 12.4 days. The estimate of the 
standard deviation of the random error of ultrasound assessed foetal age was 5.2 
days. 
Conclusion: Even when the last menstrual period is reliable, the biologic variation of 
the time from last menstrual period to the real start of pregnancy is substantial, and 
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must be taken into account. Reliable information about the first day of the last 
menstrual period is not equivalent with reliable information about the start of 
pregnancy. 
© 2005 Elsevier Ireland Ltd. All rights reserved. 
1. Introduction 
In human pregnancies, the day of the onset of 
pregnancy is usually unknown. The first day of the 
last menstrual period (LMP) is used as a surrogate 
variable. When we count pregnancy duration from 
LMP, we introduce a random error which is the 
biologic variation of the interval from LMP to the 
proper start of pregnancy. The length of human 
gestation from start of pregnancy to delivery is also 
subject to biologic variation. Remarkably, little is 
known about the biologic variations of these two 
partitions of gestation in normal spontaneous 
pregnancies [1]. 
According to the tradition usually attributed to 
Nägele [2], the delivery can be expected about 280 
days from the LMP. In modern obstetrics, term 
prediction based on ultrasound assessment of 
gestational age has become the preferred method. 
However, the ultrasound method is also subject to 
random variation. 
Purpose of the present paper is to assess and 
discuss the random variation or biologic variation of 
the two partitions of human gestation, and the 
random variation of gestational age assessment 
based on ultrasound. 
mean, measured by the standard deviation (σ ) 
or the squared value which is the variance. 
The random error of the Nägele prediction 
method is a combination of the biologic variation 
of the time from LMP to start of pregnancy (P) and 
the biologic variation of the duration of human 
gestation from start of pregnancy to delivery (G). 
The variance of the term prediction according to 
Nägele is the sum of the variance of these two 
partitions of pregnancy: 
 
222
GPLMP σσσ +=   
 
(see Appendix A for details). 
Ultrasound assessment of gestational length is 
based upon biometric measurement in early preg-
nancy and comparison of obtained values with a set 
of normal values. The foetal age at the time of 
ultrasound is termed A in Fig. 1, and the expected 
day of delivery is calculated from A assuming a 
fixed gestational length of usually 280 days as in 
the Nägele method. 
The random error of the ultrasound method for 
term prediction is a combination of the random 
error of ultrasound assessed foetal age (A) and the 
biologic variation of human gestation from start of 
pregnancy to delivery (G). The variance of ultra-
sound term prediction can be written as: 
  
2. Method 
2.1. The variation of the different 
parameters of the pregnancy 
In Fig. 1, the interval from the LMP to the start of 
pregnancy is labelled P, and the interval from start 
of pregnancy to delivery is labelled G. The mean 
difference between observed and expected day of 
delivery is the systematic error of term prediction. 
The random error is the distribution around the 
  
  
The variance of the difference between the 
two predicted days of delivery is the sum of 
the variance of time from LMP to start of 
pregnancy and the variance of gestational age at 
the time of ultrasound measurement (see 
Appendix A for details): 
  
We can insert measured values for the para-
meters in the left side of all three equations (I), (II) 
 
 
 
 
Figure 1 Different components of the total gestational period: P is the interval from the first day of last menstrual 
period (LMP) to start of pregnancy, G is the time from start of pregnancy to spontaneous delivery and A is the foetal age 
at the time of routine ultrasound measurement. 
(I)
(II)
(III)
Start of 
pregnancy 
Ultrasound 
examination 
LMP 
A 
Day of delivery 
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Table 1 Exclusions from the background population 
of 19,823 deliveries (100%), some of the exclusions 
were for multiple reasons 
 
Number            % 
Duplex pregnancies 593 (3-0) 
No LMP recorded 2069 (10.4)
No ultrasound exam 627 (3.2) 
BPD outside range 34—51 mm 1943 (9.8) 
Induced labour 1206 (6.0) 
Elective Caesarean section 1019 (5.1) 
Oral contraceptives used 4321 (21.8)
The remaining study population consists of 11,238 pregnan-
cies (56.7%). 
and (III). We can then combine and solve the 
equations to calculate estimates of Aσ , Pσ   
and Gσ . The underlying assumptions are that the 
term is predicted with two independent methods, 
and that the factors A, G and P are mutually 
independent. 
2.2. The clinical material 
We analysed a geographically based cohort of 
deliveries comprising women residing in Oppland 
county, Norway. The county has two equally sized 
obstetrical departments, with a total of approxi-
mately 2000 deliveries annually. When the 
patients are discharged from the hospitals after 
delivery, information about the pregnancy and the 
delivery is prospectively recorded in an obstetrical 
database by senior obstetricians examining the 
records. 
All pregnant women in the county are routinely 
offered an ultrasound examination in gestational 
weeks 17 to 19, approximately 97% of the women 
accepted and are examined by trained midwives 
and gynaecologists. During the ultrasound session, 
the women are interviewed about their menstrual 
history. LMP term is calculated and recorded only 
if the date of the LMP is recalled with certainty 
and the menstruation was regular with interval 
within 26-32 days, and oral contraceptives were 
not used during the last 3 months before preg-
nancy. When these conditions are not met, LMP 
term is classified as unreliable and is not 
recorded. LMP term was calculated by adding 
282 days to the LMP. 
Ultrasound term was based on measurement 
of the foetal biparietal diameter between 
gestational weeks 15 and 20. During the time 
when the data were collected, the standard 
Norwegian normal curves (Eik-Nes SH, Grøttum 
P. Graviditetskalenderen Snurra, Scan-Med a/s, 
Drammen, Norway) were used. Clinical manage-
ment was based on the ultrasound term. 
Ultrasound term and LMP-term were determined 
independently. 
For the purpose of the present study, we 
recomputed the ultrasound term using the recently 
published ultrasound charts [3]. We calculated 
ultrasound predicted term of delivery based on 
282 days expected duration of pregnancy. 
Eligible for the study were women with 
singleton pregnancies and spontaneous onset of 
000- 
32 33 34 36 37 38 39 40 41 42 43 44 45 46 47 
Weeks 
────     LMP 
— —         Ultrasound 
Figure 2    Distribution of deliveries around ultrasound term and term calculated from last menstrual period (n = 11,238 
singleton, spontaneous onset of labour). 
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Table 2    Mean difference (days) between actual day of delivery and predicted day of delivery, and the mean 
difference between the two predicted terms 
 
 Mean Median Mode Range S.D. variance 
Actual-LMP predicted day of delivery 
Actual-ultrasound predicted day of delivery 
Term ultrasound— term LMP 
-0 .1  
 - 0 . 7  
0.7 
1 
   1 
   0 
2  
3 
 - 1 
- 143 to 84 
   - 145 to 60 
    - 92 to 85 
14.3 
13.0 
7.9 
204.1 
168.2 
63.0 
Median, mode, range, standard deviation (S.D.) and variance of the differences are shown (n = 11,238 deliveries, reliable last 
menstrual period, singleton pregnancies, spontaneous onset of labour). 
labour, where both an ultrasound term based on 
second trimester BPD measurement and an LMP-
term was recorded. Elective Caesarean sections 
and cases where labour was induced were 
excluded. From a total of 19,823 deliveries 
recorded in the database from 1989 to 1999 we 
excluded 8585 deliveries, details are shown in 
Table 1. A total of 11,238 deliveries (56.7%) 
remained for analysis. 
Data were managed and analysed with SPSS 
version 12.0. 
3. Results 
The distribution of the deliveries around the 
expected day is shown in Fig. 2, according to 
ultrasound and LMP. The mean difference between 
observed and LMP-predicted day of delivery was -
0.1 days and the variance of the difference was 
204.1 days. The mean difference between actual 
day of delivery and ultrasound predicted day of 
delivery was - 0.7 days and the variance was 168.2 
days (Table 2). 
The computed variances (Table 2) were 
inserted in Eqs. (I), (II) and (III). The results 
are summarised in Table 3. The standard deviation 
of the period from LMP to start of pregnancy ( Pσ ) 
was 7.0 days, the standard deviation of the period 
from this point in time to delivery ( Gσ ) was 12.4 
days and the standard deviation of the gestational 
age at the time of ultrasound dating ( Aσ ) was 5.2 
days (Table 3). 
Table 3 Estimates of the variance (days) of the time 
from last menstrual period (LMP) to start of pregnancy 
and of the variance of the time from start of 
pregnancy to delivery and of the random error of 
ultrasound at the time of ultrasound measurement 
 
 Variance S.D. 
Time from LMP to start of pregnancy 49.5 7.0
Time from pregnancy start to delivery 154.7 12.4
Random error of ultrasound 27.1 5.2
The standard deviations (S.D.) are also listed. 
4. Discussion 
Clinical materials are always censured, as a large 
proportion of pregnant women do not continue 
their pregnancies until spontaneous labour but 
are delivered by Caesarean section or after 
induction of labour, for medical reason. These 
interventions will affect the distribution of deliv-
eries around the expected term. When ultrasound 
and LMP are compared, the results of term 
prediction will probably be biased in favour of 
the ultrasound method because clinical decisions 
are based on ultrasound rather that LMP term. To 
reduce this bias, we used the new Norwegian 
standard charts to construct an expected day of 
delivery rather than using the ultrasound term 
actually determined at the routine ultrasound 
examination. 
As shown in Table 1, the elective Caesarean 
section rate (5.1%) and the induction rate (6.0%) 
in the study population were low. The policy 
concerning post term pregnancies was conserva-
tive following the standard Norwegian guidelines 
[4], where uncomplicated pregnancies are allowed 
to continue until 43 weeks with close follow up 
during week 42. The low intervention rates imply 
that bias due to censoring is minimized, as far as 
possible. 
Our method is based on the assumption that the 
two prediction methods are independent. Ultra-
sound charts are developed from measurements in 
pregnant women with certain dates based on LMP, 
so the two methods can be said to be related. At 
the time of ultrasound measurement, the foetus 
may be larger or smaller than expected, but 
gestational age is determined solely from the size 
of the foetus with no adjustments for example 
according to LMP or known date of cohabitation. 
Thus, because the two methods were used inde-
pendently we believe that our assumption is 
correct. 
Some of our estimates can be compared to 
measured values obtained in clinical studies. In 
studies of pregnancies following in-vitro fertiliza-
tion [5—11], the random error of ultrasound 
assessed gestational length range from 4.2 days to 
Reliable LMP and start of pregnancy 837   
  
1.8 days (standard deviation). Thus, our estimate of 
5.2 days (Table 3) is somewhat larger than reported 
values. The cited studies [5-11] are from centres 
of excellence and contain up to 200-300 pregnan-
cies after in-vitro fertilization whereas our material 
is from a routine clinical setting with over 11,000 
normal pregnancies. Thus, differences in the clin-
ical settings and the different sample sizes may 
explain the difference between our estimates and 
observed random measurement errors. 
We estimated the random variation of the time 
from LMP to the proper start of pregnancy to 7.0 
days (Table 3). There are two more publications 
where this time period was estimated in large 
clinical materials, albeit using other approaches. 
Mongelli and Opatola [12] estimated the standard 
deviation to 7.4 days, and Todros et al. reported 
7.16 days [13], both estimates are fairly similar to 
our estimate of 7.0 days. 
It is of great practical importance to know when 
pregnancy starts in the menstrual cycle and to 
know the biologic variation of this parameter. The 
time of conception or the time of implantation may 
both be defined as the start of pregnancy, and the 
interval between these two events also has a 
biologic variation. For simplicity and also because 
it is not possible for us to distinguish further, in the 
present study we use we use the neutral term start 
of pregnancy. 
The scarcity of research about when pregnancy 
actually starts is remarkable. Three older studies 
used the day of the basal body temperature 
increase as marker, and standard deviations of 7.3 
days [14], 7.6 days [15] and 9.9 days [16] are 
reported. 
In a recent, well-conducted study using sophis-
ticated serial urine hormone analysis, Baird et al. 
[17] showed that day 14 was the most frequent day 
of ovulation with a standard deviation of 6.7 days. 
In another study based on the same material, the 
mean interval from ovulation to implantation was 
9.1 days ranging from 6 to 12 days, the standard 
deviation was not reported [18]. To sum up, our 
estimate of a standard deviation of 7.0 days of the 
interval from LMP to start of pregnancy seems quite 
reasonable when compared with other estimates 
and reported observations. The practical implica-
tion of this result is that doctors, midwives and 
pregnant women as well, should realise that the 
biologic variations are considerable and that preg-
nancy may start virtually at any time during the 
menstrual cycle [1]. 
The gestational period from start of pregnancy 
to delivery after spontaneous labour had a stan-
dard deviation of 12.4 days (Table 3). Thus, even 
if we did know the exact time when pregnancy 
starts in humans, gestational length to spontane-
ous labour is far from constant. A substantial 
variation must be taken into account, and the 
practical consequence is that we should always 
present the expected term of delivery as an 
interval rather than a fixed day. 
The utility of ultrasound is particularly high 
when the information about LMP is uncertain or 
missing. But even when the information about 
LMP is reliable as in our material, gestational age 
is more precisely assessed with ultrasound, as 
indicated by the distribution of deliveries around 
the expected term which is narrower for ultra-
sound than LMP (Table 2, Fig. 2). It is tempting to 
compare the random variation of menstrual 
dating of pregnancy (7.0 days) with the random 
error of ultrasound (5.2 days, Table 3), but 
because the distributions of these two parameters 
are different the standard deviations cannot be 
compared directly. The random error of ultra-
sound is normally distributed but the distribution 
of the time of the start of pregnancy is skewed 
and probably similar to the distribution of the 
ovulation, where there is a tendency towards long 
intervals between LMP and start of pregnancy 
[17,18]. 
More than 50 years ago, Schildbach [14] ob-
served that gestational length at delivery had a 
much narrower distribution when he counted 
pregnancy duration from the time of ovulation 
rather than from LMP. His correct interpretation 
was that the time of implantation was not constant 
but varied in the menstrual cycle. His major 
concern was the forensic experts' practise in 
paternity cases, where the information about LMP 
was trusted and the inherent biologic uncertainty 
was neglected. 
5. Conclusion 
The biologic variation associated with start of 
pregnancy is large, and this knowledge has 
LMPlications for how we should interpret a 
pregnant woman's information about the LMP. 
There is no reason to distrust or write off a 
pregnant woman's report about LMP as unlikely. 
The large biologic variation explains why reliable 
information about LMP is not equivalent with 
reliable information about start of pregnancy [19]. 
Also, the biologic variation of gestational length is 
large and the day of spontaneous labour cannot 
be predicted with high precision. The expected 
term of delivery should rather be expressed as an 
interval than a specific day. 
838 J. Nakling et al.   
  
Appendix A 
A. 1 . Prediction of the day of delivery based 
on last menstrual period 
As shown in Fig. 1 , the day of delivery (DDLMP) can 
be expressed as the sum of the time from the LMP 
to the start of pregnancy, and the time from start 
of pregnancy to delivery: 
DDLMP = LMP + P + G  
The difference between observed and expected 
day of delivery is: LMP+P+G -(LMP + P' + G') = 
P-P' + G-G', where P' and G' are the expected 
values. According to statistical theory, the variance 
of the sum of two independent stochastic variables 
is equal to the sum of the variances. Assumed that 
P and G are independent, the variance of the 
difference is: 
As both US and LMP have fixed values, the variance 
of this difference is: 
222
APDIFF σσσ +=  
In Eqs. (I), (II) and (III), three variables are unknown 
( 2Gσ , 2Pσ  and 2Aσ ).  When we solve the three 
equations with respect to the three unknown 
variables, we get: 
2
Gσ =( 2LMPσ + 2USσ - 2DIFFσ )/2 
 
2
Pσ =( 2LMPσ - 2USσ + 2DIFFσ )/2 
 
2
Aσ =(- 2LMPσ + 2USσ + 2DIFFσ )/2 
 
Values for 2LMPσ , 2USσ  and 2DIFFσ  can be taken from 
clinical materials (Table 2), and estimates for 
2
Aσ , 2Gσ and 2Pσ  can then be calculated. 
  
222
GPLMP σσσ +=                           (I) 
where 2Pσ  is the variance of the time from LMP to 
start of pregnancy and 2Gσ  is the variance of the 
gestational length from start of pregnancy to 
delivery. 
A.2. Prediction of term with ultrasound 
Gestational age (A) is assessed with ultrasound at 
the routine ultrasound examination. From Fig. 1, 
we can write the expected day of delivery accord-
ing to ultrasound (DDUS): 
DDUS = US - A + G 
where US is the day of the ultrasound examination, 
A is the foetal age at the time of measurement and 
G again is the gestational period from start of 
pregnancy to delivery (Fig. 1). The difference 
between observed and expected day of delivery is: 
US - A + G - (US - A' + G') = A' - A + G - G', 
where A' is the foetal age according to ultrasound 
and A is the true value, G' the expected gestational 
duration to delivery and G is the true value. 
Assumed that A and G are independent, the 
variance of the difference between true and 
expected values is: 
222
GAUS σσσ +=  (II) 
A. 3. Difference between the two predictions 
Using the equations above, the difference between 
the two predicted days of delivery is: 
DDLMP- DDUS = LMP + P + G - (US - A + G) 
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